Dermatan sulfate and chondroitin 4-sulfate (DS and CS-A)

Dermatan sulfate and chondroitin 4-sulfate are closely related sulfated glycosaminoglycans. Chondroitin 4-sulfate (CS-A) consists of repeating disaccharide units of D-glucuronic acid and N-acetylgalactosamine with sulfation at position 4 of galactosamine. Dermatan sulfate has a similar structure but features iduronic acid (from epimerized glucuronic acid) and its own unique sulfation pattern. Both are covalently linked to core proteins as proteoglycans, which are integral to the extracellular matrix and cell surface, providing structural support and regulating protein interactions. They play roles in cartilage integrity, vascular biology, neural tissue injury/repair, and are implicated in various diseases including atherosclerosis, cancer, neurodegenerative disease, and connective tissue disorders. They are not single molecular targets for drugs in the classical sense but are increasingly recognized as important functional regulators and therapeutic modulators in tissue biology and disease.

Other names

Chondroitin sulfate (CS; for chondroitin 4-sulfate subclass often called CS-A)Dermatan (former name: chondroitin sulfate B)DSChondroitin sulfate A (CS-A)Chondroitin-4-sulfate (systematic for CS-A)

As a supplement, chondroitin sulfate is proposed to contribute to cartilage support and joint health via structural integration, water retention, and possible anti-inflammatory activity. Chondroitinase enzymes degrade CS/DS chains to disrupt inhibitory barriers post CNS injury, improving neural regeneration.